The Ensign Group, Inc.
ENSGNASDAQHealthcareMedical Care Facilities
As of Oct 23, 2026 close
- Market cap
- $10.44B
- P/E (TTM)
- 27.58
- Forward P/E
- 23.81
- Dividend yield
- 0.15%
- 52-week range
- $141.58$218.00
- Volume (live)
- -
- Avg. volume (3M)
- 345.02K
The Ensign Group (ENSG) Stock Price & Financial Analysis
The Ensign Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $175.59 - $178.27 |
|---|---|
| 52-Week High | $218.00 |
| 52-Week Low | $141.58 |
| Open | $177.54 |
| Volume (last close) | 248.73K |
| Average Volume (3M) | 345.02K |
| Revenue (TTM) | 5.49B |
|---|---|
| Net Income (TTM) | 378.70M |
| Free Cash Flow (TTM) | 419.09M |
| EPS (TTM) | $6.38 |
| Profit Margin | 6.90% |
| Operating Margin | 8.52% |
| Return on Equity (ROE) | 15.49% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.26 |
|---|---|
| Dividend Yield | 0.15% |
| Payout Ratio | 4.07% |
| Last Dividend Ex-Date | Sep 30, 2026 |
| Market Cap | 10.44B |
|---|---|
| Shares Outstanding | 59.48M |
| P/E Ratio (TTM) | 27.58 |
| Forward P/E | 23.81 |
| Price to Sales (P/S) | 1.90 |
| Price to Book (P/B) | 4.27 |
| EV/EBITDA | 17.38 |
| 50-Day MA | $175.31 |
|---|---|
| 200-Day MA | $181.59 |
| 1-Year Change | −3.79% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
The Ensign Group at a Glance
As of the Oct 23, 2026 close, The Ensign Group (ENSG) has a market capitalization of $10.44B. The stock trades at 27.6× trailing earnings, 23.8× forward earnings and 1.9× sales. Over the trailing twelve months it earned $378.70M on revenue of $5.49B (a 6.9% profit margin) and generated $419.09M of free cash flow. Revenue grew 18.9% year over year.
As of its latest reported balance sheet, it holds $262.30M in cash and securities against $139.74M of debt, a net cash position of $122.56M.
The Ensign Group pays a quarterly dividend totaling $0.26 per share a year, a 0.15% yield at the Oct 23, 2026 close, with a 4% payout ratio and 18 consecutive years of dividend increases.
The share price is down 3.8% over the past year. At $175.59 (the Oct 23, 2026 close) it sits within its 52-week range of $141.58 to $218.00, below its 200-day moving average of $181.59.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $219.00, 24.7% above the Oct 23, 2026 close.
Frequently Asked Questions About The Ensign Group
What is the current stock price for ENSG?
As of the Oct 23, 2026 close, ENSG stock trades at $175.59. The 52-week range is $141.58–$218.00, with a day range of $175.59–$178.27.
What is the P/E ratio for ENSG?
As of the Oct 23, 2026 close, The Ensign Group's trailing twelve-month (TTM) P/E ratio is 27.6, meaning investors pay $27.6 for every $1 of annual earnings. The forward P/E is 23.8, reflecting analyst expectations for future earnings. The Ensign Group operates in the Healthcare sector.
Does ENSG pay dividends?
Yes, The Ensign Group pays a 0.15% annual dividend yield as of the Oct 23, 2026 close ($0.26 per share a year). The trailing twelve-month payout ratio is 4.1%. The most recent ex-dividend date was September 30, 2026.
What do analysts recommend for ENSG?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for ENSG is Buy. The average 12-month price target is $219.00, a 24.7% upside from the Oct 23, 2026 close of $175.59.
What is the market cap of ENSG?
As of the Oct 23, 2026 close, The Ensign Group's market capitalization is $10.44B, classifying it as a large-cap company. The Ensign Group operates in the Healthcare sector within the Medical Care Facilities industry.